# Trade Mark Journal No.2025/037 12 September 2025

## WO0000001872444 (5)

Office of origin: United States of America

Date of International Registration:7 July 2025
Date of designation in the UK: 7 July 2025

The mark consists of three shaded chevrons with each abutting the chevron in front of it pointing to the left with a shaded triangle with one curved side to the right of and pointing in the same direction of the three chevrons.

Class 5
  Pharmaceutical preparations for the treatment of thyroid disorders; pharmaceutical preparations for the treatment of ocular disorders.

Horizon Therapeutics Ireland DAC

Representative: Elsa D. Lemoine Amgen Inc., One Amgen Center Drive, Thousand Oaks CA 91320-1799, UNITED STATES OF AMERICA